STRATEC Biomedical AG
Open
17.36 1.64
Übersicht
Veränderung der Aktienkurses
24h
Min
16.68
Max
17.68
Einkommen | 2.6M -1.7M |
|---|---|
Verkäufe | -22M 53M |
KGV Branchendurchschnitt | 14.63 30.136 |
EPS | -0.357 |
Dividendenrendite | 3.3 |
Gewinnspanne | -3.206 |
Angestellte | 1,395 |
EBITDA | -6.7M 4.1M |
Empfehlungen | Buy |
|---|---|
12-Monats-Prognose | +55.9% upside |
Dividendenrendite Branchendurchschnitt | 3.30% 3.27% |
|---|---|
Nächstes Ergebnis | 14. Aug. 2026 |
Marktkapitalisierung | 6.8M 221M |
|---|---|
Vorheriger Eröffnungskurs | 15.72 |
Vorheriger Schlusskurs | 17.36 |
STRATEC Biomedical AG Chart
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
Über STRATEC Biomedical AG
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
